 | • レポートコード：GIR-2104Z12325 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、季節性インフルエンザワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。季節性インフルエンザワクチンの種類別市場規模（タイプA（H1N1）、タイプA（H3N2）、タイプB）、用途別市場規模（小児、青年、成人、高齢者）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・季節性インフルエンザワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GlaxoSmithKline plc、Sinovac Biotech Ltd、Changsheng Bio-Technology、Ccbio SA、Aleph Biomedical、Sanofi、Jiangsu Simcere Vaxtec Bio-pharmaceutical、Dalian Hissen Bio-pharm、Abbott Laboratories、Novartis International AG ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：タイプA（H1N1）、タイプA（H3N2）、タイプB ・用途別分析2016年-2026年：小児、青年、成人、高齢者 ・季節性インフルエンザワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・季節性インフルエンザワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・季節性インフルエンザワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・季節性インフルエンザワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・季節性インフルエンザワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Seasonal Influenza Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Seasonal Influenza Vaccines size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Seasonal Influenza Vaccines market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Seasonal Influenza Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Type A (H1N1)
Type A (H3N2)
Type B
Market segment by Application can be divided into
Pediatrics
Adolescence
Adults
Elderly
The key market players for global Seasonal Influenza Vaccines market are listed below:
GlaxoSmithKline plc
Sinovac Biotech Ltd
Changsheng Bio-Technology
Ccbio SA
Aleph Biomedical
Sanofi
Jiangsu Simcere Vaxtec Bio-pharmaceutical
Dalian Hissen Bio-pharm
Abbott Laboratories
Novartis International AG
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Seasonal Influenza Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Seasonal Influenza Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Type A (H1N1)
1.2.3 Type A (H3N2)
1.2.4 Type B
1.3 Market Analysis by Application
1.3.1 Overview: Global Seasonal Influenza Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Pediatrics
1.3.3 Adolescence
1.3.4 Adults
1.3.5 Elderly
1.4 Global Seasonal Influenza Vaccines Market Size & Forecast
1.4.1 Global Seasonal Influenza Vaccines Sales in Value (2016-2026))
1.4.2 Global Seasonal Influenza Vaccines Sales in Volume (2016-2026)
1.4.3 Global Seasonal Influenza Vaccines Price by Type (2016-2026) & (USD/Unit)
1.5 Global Seasonal Influenza Vaccines Production Capacity Analysis
1.5.1 Global Seasonal Influenza Vaccines Total Production Capacity (2016-2026)
1.5.2 Global Seasonal Influenza Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Seasonal Influenza Vaccines Market Drivers
1.6.2 Seasonal Influenza Vaccines Market Restraints
1.6.3 Seasonal Influenza Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline plc
2.1.1 GlaxoSmithKline plc Details
2.1.2 GlaxoSmithKline plc Major Business
2.1.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Product and Services
2.1.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Sinovac Biotech Ltd
2.2.1 Sinovac Biotech Ltd Details
2.2.2 Sinovac Biotech Ltd Major Business
2.2.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Product and Services
2.2.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Changsheng Bio-Technology
2.3.1 Changsheng Bio-Technology Details
2.3.2 Changsheng Bio-Technology Major Business
2.3.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Product and Services
2.3.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Ccbio SA
2.4.1 Ccbio SA Details
2.4.2 Ccbio SA Major Business
2.4.3 Ccbio SA Seasonal Influenza Vaccines Product and Services
2.4.4 Ccbio SA Seasonal Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Aleph Biomedical
2.5.1 Aleph Biomedical Details
2.5.2 Aleph Biomedical Major Business
2.5.3 Aleph Biomedical Seasonal Influenza Vaccines Product and Services
2.5.4 Aleph Biomedical Seasonal Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Seasonal Influenza Vaccines Product and Services
2.6.4 Sanofi Seasonal Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Jiangsu Simcere Vaxtec Bio-pharmaceutical
2.7.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Details
2.7.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Major Business
2.7.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product and Services
2.7.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Dalian Hissen Bio-pharm
2.8.1 Dalian Hissen Bio-pharm Details
2.8.2 Dalian Hissen Bio-pharm Major Business
2.8.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product and Services
2.8.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Abbott Laboratories
2.9.1 Abbott Laboratories Details
2.9.2 Abbott Laboratories Major Business
2.9.3 Abbott Laboratories Seasonal Influenza Vaccines Product and Services
2.9.4 Abbott Laboratories Seasonal Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Novartis International AG
2.10.1 Novartis International AG Details
2.10.2 Novartis International AG Major Business
2.10.3 Novartis International AG Seasonal Influenza Vaccines Product and Services
2.10.4 Novartis International AG Seasonal Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Seasonal Influenza Vaccines Sales by Manufacturer
3.1 Global Seasonal Influenza Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Seasonal Influenza Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Seasonal Influenza Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Seasonal Influenza Vaccines Manufacturer Market Share
3.4.2 Top 6 Seasonal Influenza Vaccines Manufacturer Market Share
3.5 Global Seasonal Influenza Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Seasonal Influenza Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Seasonal Influenza Vaccines Market Size by Region
4.1.1 Global Seasonal Influenza Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global Seasonal Influenza Vaccines Revenue by Region (2016-2026)
4.2 North America Seasonal Influenza Vaccines Revenue (2016-2026)
4.3 Europe Seasonal Influenza Vaccines Revenue (2016-2026)
4.4 Asia-Pacific Seasonal Influenza Vaccines Revenue (2016-2026)
4.5 South America Seasonal Influenza Vaccines Revenue (2016-2026)
4.6 Middle East and Africa Seasonal Influenza Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Seasonal Influenza Vaccines Sales in Volume by Type (2016-2026)
5.2 Global Seasonal Influenza Vaccines Revenue by Type (2016-2026)
5.3 Global Seasonal Influenza Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Seasonal Influenza Vaccines Sales in Volume by Application (2016-2026)
6.2 Global Seasonal Influenza Vaccines Revenue by Application (2016-2026)
6.3 Global Seasonal Influenza Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Seasonal Influenza Vaccines Sales by Type (2016-2026)
7.2 North America Seasonal Influenza Vaccines Sales by Application (2016-2026)
7.3 North America Seasonal Influenza Vaccines Market Size by Country
7.3.1 North America Seasonal Influenza Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America Seasonal Influenza Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Seasonal Influenza Vaccines Sales by Type (2016-2026)
8.2 Europe Seasonal Influenza Vaccines Sales by Application (2016-2026)
8.3 Europe Seasonal Influenza Vaccines Market Size by Country
8.3.1 Europe Seasonal Influenza Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe Seasonal Influenza Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Seasonal Influenza Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific Seasonal Influenza Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific Seasonal Influenza Vaccines Market Size by Region
9.3.1 Asia-Pacific Seasonal Influenza Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Seasonal Influenza Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Seasonal Influenza Vaccines Sales by Type (2016-2026)
10.2 South America Seasonal Influenza Vaccines Sales by Application (2016-2026)
10.3 South America Seasonal Influenza Vaccines Market Size by Country
10.3.1 South America Seasonal Influenza Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America Seasonal Influenza Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Seasonal Influenza Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa Seasonal Influenza Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa Seasonal Influenza Vaccines Market Size by Country
11.3.1 Middle East & Africa Seasonal Influenza Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Seasonal Influenza Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Seasonal Influenza Vaccines Typical Distributors
12.3 Seasonal Influenza Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Seasonal Influenza Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Seasonal Influenza Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline plc Major Business
Table 5. GlaxoSmithKline plc Seasonal Influenza Vaccines Product and Services
Table 6. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sinovac Biotech Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Sinovac Biotech Ltd Major Business
Table 9. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product and Services
Table 10. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Changsheng Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 12. Changsheng Bio-Technology Major Business
Table 13. Changsheng Bio-Technology Seasonal Influenza Vaccines Product and Services
Table 14. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Ccbio SA Basic Information, Manufacturing Base and Competitors
Table 16. Ccbio SA Major Business
Table 17. Ccbio SA Seasonal Influenza Vaccines Product and Services
Table 18. Ccbio SA Seasonal Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Aleph Biomedical Basic Information, Manufacturing Base and Competitors
Table 20. Aleph Biomedical Major Business
Table 21. Aleph Biomedical Seasonal Influenza Vaccines Product and Services
Table 22. Aleph Biomedical Seasonal Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Seasonal Influenza Vaccines Product and Services
Table 26. Sanofi Seasonal Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Jiangsu Simcere Vaxtec Bio-pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Jiangsu Simcere Vaxtec Bio-pharmaceutical Major Business
Table 29. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product and Services
Table 30. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Dalian Hissen Bio-pharm Basic Information, Manufacturing Base and Competitors
Table 32. Dalian Hissen Bio-pharm Major Business
Table 33. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product and Services
Table 34. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 36. Abbott Laboratories Major Business
Table 37. Abbott Laboratories Seasonal Influenza Vaccines Product and Services
Table 38. Abbott Laboratories Seasonal Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Novartis International AG Basic Information, Manufacturing Base and Competitors
Table 40. Novartis International AG Major Business
Table 41. Novartis International AG Seasonal Influenza Vaccines Product and Services
Table 42. Novartis International AG Seasonal Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Seasonal Influenza Vaccines Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Seasonal Influenza Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Seasonal Influenza Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Seasonal Influenza Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Seasonal Influenza Vaccines Production Site of Key Manufacturer
Table 48. Global Seasonal Influenza Vaccines Sales by Region (2016-2021e) & (K Units)
Table 49. Global Seasonal Influenza Vaccines Sales by Region (2021-2026) & (K Units)
Table 50. Global Seasonal Influenza Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Seasonal Influenza Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Seasonal Influenza Vaccines Sales by Type (2016-2021e) & (K Units)
Table 53. Global Seasonal Influenza Vaccines Sales by Type (2021-2026) & (K Units)
Table 54. Global Seasonal Influenza Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Seasonal Influenza Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Seasonal Influenza Vaccines Price by Type (2016-2021e) & (USD/Unit)
Table 57. Global Seasonal Influenza Vaccines Price by Type (2021-2026) & (USD/Unit)
Table 58. Global Seasonal Influenza Vaccines Sales by Application (2016-2021e) & (K Units)
Table 59. Global Seasonal Influenza Vaccines Sales by Application (2021-2026) & (K Units)
Table 60. Global Seasonal Influenza Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Seasonal Influenza Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Seasonal Influenza Vaccines Price by Application (2016-2021e) & (USD/Unit)
Table 63. Global Seasonal Influenza Vaccines Price by Application (2021-2026) & (USD/Unit)
Table 64. North America Seasonal Influenza Vaccines Sales by Country (2016-2021e) & (K Units)
Table 65. North America Seasonal Influenza Vaccines Sales by Country (2021-2026) & (K Units)
Table 66. North America Seasonal Influenza Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Seasonal Influenza Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Seasonal Influenza Vaccines Sales by Type (2016-2021e) & (K Units)
Table 69. North America Seasonal Influenza Vaccines Sales by Type (2021-2026) & (K Units)
Table 70. North America Seasonal Influenza Vaccines Sales by Application (2016-2021e) & (K Units)
Table 71. North America Seasonal Influenza Vaccines Sales by Application (2021-2026) & (K Units)
Table 72. Europe Seasonal Influenza Vaccines Sales by Country (2016-2021e) & (K Units)
Table 73. Europe Seasonal Influenza Vaccines Sales by Country (2021-2026) & (K Units)
Table 74. Europe Seasonal Influenza Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Seasonal Influenza Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Seasonal Influenza Vaccines Sales by Type (2016-2021e) & (K Units)
Table 77. Europe Seasonal Influenza Vaccines Sales by Type (2021-2026) & (K Units)
Table 78. Europe Seasonal Influenza Vaccines Sales by Application (2016-2021e) & (K Units)
Table 79. Europe Seasonal Influenza Vaccines Sales by Application (2021-2026) & (K Units)
Table 80. Asia-Pacific Seasonal Influenza Vaccines Sales by Region (2016-2021e) & (K Units)
Table 81. Asia-Pacific Seasonal Influenza Vaccines Sales by Region (2021-2026) & (K Units)
Table 82. Asia-Pacific Seasonal Influenza Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Seasonal Influenza Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Seasonal Influenza Vaccines Sales by Type (2016-2021e) & (K Units)
Table 85. Asia-Pacific Seasonal Influenza Vaccines Sales by Type (2021-2026) & (K Units)
Table 86. Asia-Pacific Seasonal Influenza Vaccines Sales by Application (2016-2021e) & (K Units)
Table 87. Asia-Pacific Seasonal Influenza Vaccines Sales by Application (2021-2026) & (K Units)
Table 88. South America Seasonal Influenza Vaccines Sales by Country (2016-2021e) & (K Units)
Table 89. South America Seasonal Influenza Vaccines Sales by Country (2021-2026) & (K Units)
Table 90. South America Seasonal Influenza Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Seasonal Influenza Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Seasonal Influenza Vaccines Sales by Type (2016-2021e) & (K Units)
Table 93. South America Seasonal Influenza Vaccines Sales by Type (2021-2026) & (K Units)
Table 94. South America Seasonal Influenza Vaccines Sales by Application (2016-2021e) & (K Units)
Table 95. South America Seasonal Influenza Vaccines Sales by Application (2021-2026) & (K Units)
Table 96. Middle East & Africa Seasonal Influenza Vaccines Sales by Country (2016-2021e) & (K Units)
Table 97. Middle East & Africa Seasonal Influenza Vaccines Sales by Country (2021-2026) & (K Units)
Table 98. Middle East & Africa Seasonal Influenza Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Seasonal Influenza Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Seasonal Influenza Vaccines Sales by Type (2016-2021e) & (K Units)
Table 101. Middle East & Africa Seasonal Influenza Vaccines Sales by Type (2021-2026) & (K Units)
Table 102. Middle East & Africa Seasonal Influenza Vaccines Sales by Application (2016-2021e) & (K Units)
Table 103. Middle East & Africa Seasonal Influenza Vaccines Sales by Application (2021-2026) & (K Units)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Seasonal Influenza Vaccines Typical Distributors
Table 107. Seasonal Influenza Vaccines Typical Customers
List of Figures
Figure 1. Seasonal Influenza Vaccines Picture
Figure 2. Global Seasonal Influenza Vaccines Sales Market Share by Type in 2020
Figure 3. Type A (H1N1)
Figure 4. Type A (H3N2)
Figure 5. Type B
Figure 6. Global Seasonal Influenza Vaccines Sales Market Share by Application in 2020
Figure 7. Pediatrics
Figure 8. Adolescence
Figure 9. Adults
Figure 10. Elderly
Figure 11. Global Seasonal Influenza Vaccines Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Seasonal Influenza Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Seasonal Influenza Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Seasonal Influenza Vaccines Sales (2016-2026) & (K Units)
Figure 33. Global Seasonal Influenza Vaccines Production Capacity (2016-2026) & (K Units)
Figure 34. Global Seasonal Influenza Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Seasonal Influenza Vaccines Market Drivers
Figure 36. Seasonal Influenza Vaccines Market Restraints
Figure 37. Seasonal Influenza Vaccines Market Trends
Figure 38. Global Seasonal Influenza Vaccines Sales Market Share by Manufacturer in 2020
Figure 39. Global Seasonal Influenza Vaccines Revenue Market Share by Manufacturer in 2020
Figure 40. Seasonal Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Seasonal Influenza Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Seasonal Influenza Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Seasonal Influenza Vaccines Sales Market Share by Region (2016-2026)
Figure 44. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2016-2026)
Figure 45. North America Seasonal Influenza Vaccines Revenue (2016-2026) & (USD Million)
Figure 46. Europe Seasonal Influenza Vaccines Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Seasonal Influenza Vaccines Revenue (2016-2026) & (USD Million)
Figure 48. South America Seasonal Influenza Vaccines Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Seasonal Influenza Vaccines Revenue (2016-2026) & (USD Million)
Figure 50. Global Seasonal Influenza Vaccines Sales Market Share by Type (2016-2026)
Figure 51. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2016-2026)
Figure 52. Global Seasonal Influenza Vaccines Price by Type (2016-2026) & (USD/Unit)
Figure 53. Global Seasonal Influenza Vaccines Sales Market Share by Application (2016-2026)
Figure 54. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2016-2026)
Figure 55. Global Seasonal Influenza Vaccines Price by Application (2016-2026) & (USD/Unit)
Figure 56. North America Seasonal Influenza Vaccines Sales Market Share by Country (2016-2026)
Figure 57. North America Seasonal Influenza Vaccines Revenue Market Share by Country (2016-2026)
Figure 58. North America Seasonal Influenza Vaccines Sales Market Share by Type (2016-2026)
Figure 59. North America Seasonal Influenza Vaccines Sales Market Share by Application (2016-2026)
Figure 60. Europe Seasonal Influenza Vaccines Sales Market Share by Country (2016-2026)
Figure 61. Europe Seasonal Influenza Vaccines Revenue Market Share by Country (2016-2026)
Figure 62. Europe Seasonal Influenza Vaccines Sales Market Share by Type (2016-2026)
Figure 63. Europe Seasonal Influenza Vaccines Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Seasonal Influenza Vaccines Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Seasonal Influenza Vaccines Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Seasonal Influenza Vaccines Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Seasonal Influenza Vaccines Sales Market Share by Application (2016-2026)
Figure 68. South America Seasonal Influenza Vaccines Sales Market Share by Country (2016-2026)
Figure 69. South America Seasonal Influenza Vaccines Revenue Market Share by Country (2016-2026)
Figure 70. South America Seasonal Influenza Vaccines Sales Market Share by Type (2016-2026)
Figure 71. South America Seasonal Influenza Vaccines Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Seasonal Influenza Vaccines Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Seasonal Influenza Vaccines Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Seasonal Influenza Vaccines Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Seasonal Influenza Vaccines Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の季節性インフルエンザワクチン治療薬市場規模・現状・予測（2021年-2027年） Influenza vaccine typically known as flu shot and is used for protection against influenza virus. Market Analysis and Insights: Global Seasonal Influenza Vaccines Therapeutics Market The global Seasonal Influenza Vaccines Therapeutics market size is projected to reach US$ XX million by 2026, from U…- 世界の季節性インフルエンザワクチン治療薬市場 2021：企業別、地域別、種類・用途別 The Seasonal Influenza Vaccines Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 季節性インフルエンザワクチンの世界市場2020年：分析と予測（～2025年） This report describes the global market size of Seasonal Influenza Vaccine from 2015 to 2019 and its CAGR from 2015 to 2019, and also forecasts its market size to the end of 2025 and its CAGR from 2020 to 2025. For geography segment, regional supply, demand, major players, price is presented from 20…
- 世界の抗インフルエンザ薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-influenza Drugs Market The global Anti-influenza Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界の季節性情動障害治療市場規模・現状・予測（2021年-2027年） Seasonal Affective Disorder is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people between th…